Aytu BioPharma, Inc.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2015
Total Assets: $18.2M
Liabilities Breakdown FY2015
Total Liabilities: $2.6M
Asset Breakdown
Total Assets: $18.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.4M | 40.4% |
| Accounts Receivable | $157.1K | 0.9% |
| Inventory | $39.4K | 0.2% |
| Property, Plant & Equipment | $29.7K | 0.2% |
| Goodwill | $74.0K | 0.4% |
| Intangible Assets | $628.8K | 3.5% |
| Other Assets | $9.9M | 54.5% |
Liabilities Breakdown
Total Liabilities: $2.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.6M | 100.0% |